Novel roles of U1 snRNP in alternative splicing regulation

RNA Biology

Volumn 7, Issue 4, 2010, Pages 412-419

  Buratti, Emanuele ^a   Baralle, Diana ^b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

5 splice site; Alternative splicing; pre mRNA processing; U1snRNP

Indexed keywords

MESSENGER RNA; RNA POLYMERASE II; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMALL NUCLEAR RNA;

ALTERNATIVE RNA SPLICING; EUKARYOTE; GENE SILENCING; HUMAN; NONHUMAN; PROTEIN RNA BINDING; REVIEW; RNA DEGRADATION; RNA SEQUENCE; ROUS SARCOMA ONCOVIRUS;

EID: 77957307937     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.7.4.12153     Document Type: Review

References (102)

1. Maniatis T, Reed R. An extensive network of coupling among gene expression machines. Nature 2002; 416:499-506. (Pubitemid 34288845)
2. Park JW, Graveley BR. Complex alternative splicing. Adv Exp Med Biol 2007; 623:50-63.
3. Xing Y, Lee C. Alternative splicing and RNA selection pressure - evolutionary consequences for eukaryotic genomes. Nat Rev Genet 2006; 7:499-509.
4. Tarrio R, Ayala FJ, Rodriguez-Trelles F. Alternative splicing: a missing piece in the puzzle of intron gain. Proc Natl Acad Sci USA 2008; 105:7223-8.
5. Li Q, Lee JA, Black DL. Neuronal regulation of alternative pre-mRNA splicing. Nat Rev Neurosci 2007; 8:819-31.
6. Sharp PA. Split genes and RNA splicing. Cell 1994; 77:805-15.
7. Sperling J, Azubel M, Sperling R. Structure and function of the Pre-mRNA splicing machine. Structure 2008; 16:1605-15.
8. Smith CW. Alternative splicing - when two's a crowd. Cell 2005; 123:1-3.
9. Kornblihtt AR. Promoter usage and alternative splicing. Curr Opin Cell Biol 2005; 17:262-8.
10. Blaustein M, Pelisch F, Srebrow A. Signals, pathways and splicing regulation. Int J Biochem Cell Biol 2007; 39:2031-48.
11. Biamonti G, Caceres JF. Cellular stress and RNA splicing. Trends Biochem Sci 2009; 34:146-53.
12. Carmo-Fonseca M, Carvalho C. Nuclear organization and splicing control. Adv Exp Med Biol 2007; 623:1-13.
13. Schor IE, Rascovan N, Pelisch F, Allo M, Kornblihtt AR. Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing. Proc Natl Acad Sci USA 2009; 106:4325-30.
14. Hertel KJ. Combinatorial control of exon recognition. J Biol Chem 2008; 283:1211-5.
15. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, et al. Function of alternative splicing. Gene 2005; 344:1-20.
16. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008; 40:1413-5.
17. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008; 456:470-6. (Pubitemid 352759009)
18. Graveley BR. Mutually exclusive splicing of the insect Dscam pre-mRNA directed by competing intronic RNA secondary structures. Cell 2005; 123:65-73.
19. Ritchie DB, Schellenberg MJ, MacMillan AM. Spliceosome structure: piece by piece. Biochim Biophys Acta 2009; 1789:624-33.
20. Patel SB, Bellini M. The assembly of a spliceosomal small nuclear ribonucleoprotein particle. Nucleic Acids Res 2008; 36:6482-93.
21. Nilsen TW. The spliceosome: the most complex macromolecular machine in the cell? Bioessays 2003; 25:1147-9.
22. Jurica MS, Moore MJ. Pre-mRNA splicing: awash in a sea of proteins. Mol Cell 2003; 12:5-14.
23. Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009; 136:701-18.
24. Pomeranz Krummel DA, Oubridge C, Leung AK, Li J, Nagai K. Crystal structure of human spliceosomal U1 snRNP at 5.5 A resolution. Nature 2009; 458:475-80.
25. Kwek KY, Murphy S, Furger A, Thomas B, O'Gorman W, Kimura H, et al. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat Struct Biol 2002; 9:800-5. (Pubitemid 35257777)
26. Lutz CS, Murthy KG, Schek N, O'Connor JP, Manley JL, Alwine JC. Interaction between the U1 snRNP-A protein and the 160-kD subunit of cleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro. Genes Dev 1996; 10:325-37. (Pubitemid 26058965)
27. Gunderson SI, Polycarpou-Schwarz M, Mattaj IW. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol Cell 1998; 1:255-64. (Pubitemid 128378666)
28. Fortes P, Cuevas Y, Guan F, Liu P, Pentlicky S, Jung SP, et al. Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA. Proc Natl Acad Sci USA 2003; 100:8264-9.
29. Mount SM, Pettersson I, Hinterberger M, Karmas A, Steitz JA. The U1 small nuclear RNA-protein complex selectively binds a 5′ splice site in vitro. Cell 1983; 33:509-18.
30. Lerner MR, Boyle JA, Mount SM, Wolin SL, Steitz JA. Are snRNPs involved in splicing? Nature 1980; 283:220-4.
31. Rogers J, Wall R. A mechanism for RNA splicing. Proc Natl Acad Sci USA 1980; 77:1877-9.
32. Zhuang Y, Weiner AM. A compensatory base change in U1 snRNA suppresses a 5′ splice site mutation. Cell 1986; 46:827-35.
33. Seraphin B, Kretzner L, Rosbash M. A U1 snRNA:premRNA base pairing interaction is required early in yeast spliceosome assembly but does not uniquely define the 5′ cleavage site. EMBO J 1988; 7:2533-8.
34. Siliciano PG, Guthrie C. 5′ splice site selection in yeast: genetic alterations in base-pairing with U1 reveal additional requirements. Genes Dev 1988; 2:1258-67.
35. Kammler S, Leurs C, Freund M, Krummheuer J, Seidel K, Tange TO, et al. The sequence complementarity between HIV-1 5′ splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. Rna 2001; 7:421-34.
36. Zhang MQ. Statistical features of human exons and their flanking regions. Hum Mol Genet 1998; 7:919-32.
37. Sheth N, Roca X, Hastings ML, Roeder T, Krainer AR, Sachidanandam R. Comprehensive splice-site analysis using comparative genomics. Nucleic Acids Res 2006; 34:3955-67.
38. Burset M, Seledtsov IA, Solovyev VV. SpliceDB: database of canonical and non-canonical mammalian splice sites. Nucleic Acids Res 2001; 29:255-9.
39. Kyriakopoulou C, Larsson P, Liu L, Schuster J, Soderbom F, Kirsebom LA, et al. U1-like snRNAs lacking complementarity to canonical 5′ splice sites. Rna 2006; 12:1603-11. (Pubitemid 44316024)
40. Michaud S, Reed R. An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev 1991; 5:2534-46. (Pubitemid 21905937)
41. Seraphin B, Rosbash M. Identification of functional U1 snRNA-pre-mRNA complexes committed to spliceosome assembly and splicing. Cell 1989; 59:349-58. (Pubitemid 19264379)
42. Freund M, Hicks MJ, Konermann C, Otte M, Hertel KJ, Schaal H. Extended base pair complementarity between U1 snRNA and the 5′ splice site does not inhibit splicing in higher eukaryotes, but rather increases 5' splice site recognition. Nucleic Acids Res 2005; 33:5112-9. (Pubitemid 41487819)
43. Staley JP, Guthrie C. An RNA switch at the 5′ splice site requires ATP and the DEAD box protein Prp28p. Mol Cell 1999; 3:55-64. (Pubitemid 29292477)
44. Roca X, Krainer AR. Recognition of atypical 5′ splice sites by shifted base-pairing to U1 snRNA. Nat Struct Mol Biol 2009; 16:176-82.
45. Puig O, Bragado-Nilsson E, Koski T, Seraphin B. The U1 snRNP-associated factor Luc7p affects 5′ splice site selection in yeast and human. Nucleic Acids Res 2007.
46. Forch P, Puig O, Martinez C, Seraphin B, Valcarcel J. The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. EMBO J 2002; 21:6882-92. (Pubitemid 36014560)
47. Du H, Rosbash M. The U1 snRNP protein U1C recognizes the 5′ splice site in the absence of base pairing. Nature 2002; 419:86-90. (Pubitemid 34987875)
48. Reyes JL, Gustafson EH, Luo HR, Moore MJ, Konarska MM. The C-terminal region of hPrp8 interacts with the conserved GU dinucleotide at the 5′ splice site. Rna 1999; 5:167-79.
49. Shin C, Feng Y, Manley JL. Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature 2004; 427:553-8. (Pubitemid 38209114)
50. McNally LM, McNally MT. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element. J Virol 1996; 70:1163-72.
51. McNally LM, McNally MT. U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element. J Virol 1999; 73:2385-93.
52. McNally LM, Yee L, McNally MT. Two regions promote U11 small nuclear ribonucleoprotein particle binding to a retroviral splicing inhibitor element (negative regulator of splicing). J Biol Chem 2004; 279:38201-8.
53. Fogel BL, McNally MT. A cellular protein, hnRNP H, binds to the negative regulator of splicing element from Rous sarcoma virus. J Biol Chem 2000; 275:32371-8.
54. Fogel BL, McNally LM, McNally MT. Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element. Nucleic Acids Res 2002; 30:810-7.
55. Dye MJ, Gromak N, Proudfoot NJ. Exon tethering in transcription by RNA polymerase II. Mol Cell 2006; 21:849-59. (Pubitemid 43376134)
56. McNally LM, McNally MT. An RNA splicing enhancer- like sequence is a component of a splicing inhibitor element from Rous sarcoma virus. Mol Cell Biol 1998; 18:3103-11.
57. Buratti E, Baralle M, Baralle FE. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 2006; 34:3494-510.
58. Baralle M, Skoko N, Knezevich A, De Conti L, Motti D, Bhuvanagiri M, et al. NF1 mRNA biogenesis: Effect of the genomic milieu in splicing regulation of the NF1 exon 37 region. FEBS Lett 2006; 580:4449-56. (Pubitemid 44118266)
59. Dhir A, Buratti E. Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies. Febs J 2010; 277:841-55.
60. Sun H, Chasin LA. Multiple splicing defects in an intronic false exon. Mol Cell Biol 2000; 20:6414-25. (Pubitemid 30650229)
61. Sironi M, Menozzi G, Riva L, Cagliani R, Comi GP, Bresolin N, et al. Silencer elements as possible inhibitors of pseudoexon splicing. Nucleic Acids Res 2004; 32:1783-91. (Pubitemid 38832723)
62. Zhang XH, Chasin LA. Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 2004; 18:1241-50.
63. Fairbrother WG, Chasin LA. Human genomic sequences that inhibit splicing. Mol Cell Biol 2000; 20:6816-25.
64. Zhang XH, Leslie CS, Chasin LA. Dichotomous splicing signals in exon flanks. Genome Res 2005; 15:768-79.
65. Raponi M, Buratti E, Llorian M, Stuani C, Smith CW, Baralle D. Polypyrimidine tract binding protein regulates alternative splicing of an aberrant pseudoexon in NF1. Febs J 2008; 275:6101-8.
66. Coles JL, Hallegger M, Smith CW. A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F. Rna 2009; 15:33-43.
67. Pagani F, Buratti E, Stuani C, Bendix R, Dork T, Baralle FE. A new type of mutation causes a splicing defect in ATM. Nat Genet 2002; 30:426-9.
68. Buratti E, Dhir A, Lewandowska MA, Baralle FE. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. Nucleic Acids Res 2007; 35:4369-83. (Pubitemid 47248459)
69. Dhir A, Buratti E, van Santen MA, Luhrmann R, Baralle FE. The intronic splicing code: multiple factors involved in ATM pseudoexon definition. EMBO J 2010.
70. Akker SA, Misra S, Aslam S, Morgan EL, Smith PJ, Khoo B, et al. Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexon. Mol Endocrinol 2007; 21:2529-40. (Pubitemid 47529363)
71. Wang Z, Xiao X, Van Nostrand E, Burge CB. General and specific functions of exonic splicing silencers in splicing control. Mol Cell 2006; 23:61-70. (Pubitemid 43963442)
72. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, Burge CB. Systematic identification and analysis of exonic splicing silencers. Cell 2004; 119:831-45. (Pubitemid 40017689)
73. Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet 2005; 42:737-48. (Pubitemid 41475248)
74. Cooper TA, Wan L, Dreyfuss G. RNA and disease. Cell 2009; 136:777-93.
75. Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nat Biotechnol 2004; 22:535-46.
76. Baralle D, Lucassen A, Buratti E. Missed threads. The impact of pre-mRNA splicing defects on clinical practice. EMBO Rep 2009; 10:810-6.
77. Grosso AR, Martins S, Carmo-Fonseca M. The emerging role of splicing factors in cancer. EMBO Rep 2008; 9:1087-93.
78. Ghigna C, Valacca C, Biamonti G. Alternative splicing and tumor progression. Curr Genomics 2008; 9:556-70.
79. Ward AJ, Cooper TA. The pathobiology of splicing. J Pathol 2009; 220:152-63.
80. Raponi M, Baralle D. Alternative splicing: good and bad effects of translationally silent substitutions. Febs J 2010.
81. Tazi J, Bakkour N, Aboufirassi A, Branlant C. Alternative splicing in the regulation of HIV-1 multiplication -a target for therapeutic action. FEBS J 2009.
82. Garcia-Blanco MA. Making antisense of splicing. Curr Opin Mol Ther 2005; 7:476-82.
83. Cartegni L, Krainer AR. Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 2003; 10:120-5. (Pubitemid 36177092)
84. Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F. Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci USA 2003; 100:4114-9. (Pubitemid 36418166)
85. Buratti E, Baralle FE, Pagani F. Can a 'patch' in a skipped exon make the pre-mRNA splicing machine run better? Trends Mol Med 2003; 9:229-32.
86. Liu X, Jiang Q, Mansfield SG, Puttaraju M, Zhang Y, Zhou W, et al. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat Biotechnol 2002; 20:47-52.
87. Gorman L, Suter D, Emerick V, Schumperli D, Kole R. Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. Proc Natl Acad Sci USA 1998; 95:4929-34.
88. Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, et al. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 2004; 306:1796-9.
89. Cohen JB, Broz SD, Levinson AD. U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing. Mol Cell Biol 1993; 13:2666-76.
90. Baralle M, Baralle D, De Conti L, Mattocks C, Whittaker J, Knezevich A, et al. Identification of a mutation that perturbs NF1, a gene splicing using genomic DNA samples and a minigene assay. J Med Genet 2003; 40:220-2. (Pubitemid 36315397)
91. Susani L, Pangrazio A, Sobacchi C, Taranta A, Mortier G, Savarirayan R, et al. TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA. Hum Mutat 2004; 24:225-35. (Pubitemid 39095599)
92. Pinotti M, Rizzotto L, Balestra D, Lewandowska MA, Cavallari N, Marchetti G, et al. U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency. Blood 2008; 111:2681-4.
93. Tanner G, Glaus E, Barthelmes D, Ader M, Fleischhauer J, Pagani F, et al. Therapeutic strategy to rescue mutation-induced exon skipping in rhodopsin by adaptation of U1 snRNA. Hum Mutat 2009; 30:255-63.
94. Gorman L, Mercatante DR, Kole R. Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs. J Biol Chem 2000; 275:35914-9.
95. Goraczniak R, Behlke MA, Gunderson SI. Gene silencing by synthetic U1 adaptors. Nat Biotechnol 2009; 27:257-63.
96. Tarn WY, Steitz JA. SR proteins can compensate for the loss of U1 snRNP functions in vitro. Genes Dev 1994; 8:2704-17.
97. Crispino JD, Blencowe BJ, Sharp PA. Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science 1994; 265:1866-9.
98. MacMillan AM, McCaw PS, Crispino JD, Sharp PA. SC35-mediated reconstitution of splicing in U2AFdepleted nuclear extract. Proc Natl Acad Sci USA 1997; 94:133-6.
99. Crispino JD, Mermoud JE, Lamond AI, Sharp PA. Cis-acting elements distinct from the 5' splice site promote U1-independent pre-mRNA splicing. Rna 1996; 2:664-73.
100. Raponi M, Buratti E, Dassie E, Upadhyaya M, Baralle D. Low U1 snRNP dependence at the NF1 exon 29 donor splice site. Febs J 2009; 276:2060-73.
101. Fukumura K, Taniguchi I, Sakamoto H, Ohno M, Inoue K. U1-independent pre-mRNA splicing contributes to the regulation of alternative splicing. Nucleic Acids Res 2009; 37:1907-14.
102. Fukumura K, Inoue K. Role and mechanism of U1-independent pre-mRNA splicing in the regulation of alternative splicing. RNA Biol 2009; 6:395-8.